← Leaderboards
Xuemei Wu
Oregon Health & Science University
$611,963
Attributed
$611,963
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $155.3K · FY2006–11$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$611,963 · 14
By mechanism
P51$611,963 · 14
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jeffrey Jensen$3,882,169
- Alison B Edelman$5,115,754
- Alison Edelman$1,129,796
- Lucia Carbone$5,359,099
- Jing Xu$1,918,968
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroFundingResourcesGrantSourceOocytesUnited States National Institutes Of HealthInstitutionResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseMacacaGenesRna InterferenceMacaca MulattaProteinsEmbryonic DevelopmentMonkeysPrimatesNonhuman PrimateEmbryoStagingOvaryFemaleBlastocyst
Grant awards (14)
NOVEL CONTRACEPTIVES: CONTROL OF OOCYTE MATURATION$36,286
P51 · FY2011 · RR · contact PI
IDENTIFICATION/CHARACTERIZATION OF POTENTIAL NOVEL MATERNAL-EFFECT GENE PRODUCTS$47,603
P51 · FY2010 · RR · contact PI
NOVEL CONTRACEPTIVES: CONTROL OF OOCYTE MATURATION$47,603
P51 · FY2010 · RR · contact PI
CHARACTERIZATION OF ZYGOTE ARREST ONE (ZAR1) IN NONHUMAN PRIMATES$47,603
P51 · FY2010 · RR · contact PI
IDENTIFICATION/CHARACTERIZATION OF POTENTIAL NOVEL MATERNAL-EFFECT GENE PRODUCTS$60,393
P51 · FY2009 · RR · contact PI
CHARACTERIZATION OF ZYGOTE ARREST ONE (ZAR1) IN NONHUMAN PRIMATES$60,393
P51 · FY2009 · RR · contact PI
NOVEL CONTRACEPTIVES: CONTROL OF OOCYTE MATURATION$34,471
P51 · FY2009 · RR · contact PI
CHARACTERIZATION OF ZYGOTE ARREST ONE (ZAR1) IN NONHUMAN PRIMATES$11,144
P51 · FY2008 · RR · contact PI
IDENTIFICATION/CHARACTERIZATION OF NOVEL MATERNAL-EFFECT GENE PRODUCTS$11,144
P51 · FY2008 · RR · contact PI
NOVEL CONTRACEPTIVES: CONTROL OF OOCYTE MATURATION$11,144
P51 · FY2008 · RR · contact PI
IDENTIFICATION/CHARACTERIZATION OF NOVEL MATERNAL-EFFECT GENE PRODUCTS$75,850
P51 · FY2007 · RR · contact PI
CHARACTERIZATION OF ZYGOTE ARREST ONE (ZAR1) IN NONHUMAN PRIMATES$14,673
P51 · FY2007 · RR · contact PI
CHARACTERIZATION OF ZYGOTE ARREST ONE (ZAR1) IN NONHUMAN PRIMATES$76,828
P51 · FY2006 · RR · contact PI
IDENTIFICATION/CHARACTERIZATION OF POTENTIAL NOVEL MATERNAL-EFFECT GENE PRODUCTS$76,828
P51 · FY2006 · RR · contact PI